Abstract：
:A simple, efficient and reproducible method to transduce proteins into mammalian cells has not been established. Here we describe a novel protein transduction method based on a lentiviral vector. We have developed a method to package several thousand foreign protein molecules into a lentivirus-like nanoparticle (LENA) and deliver them into mammalian cells. In this proof-of-concept study, we used β-lactamase (BlaM) as a reporter molecule. The amino-terminus of BlaM was fused to the myristoylation signal of lyn, which was placed upstream of the amino-terminus of Gag (BlaM-gag-pol). By co-transfection of plasmids encoding BlaM-gag-pol and vesicular stomatitis virus-G (VSV-G) into 293T cells, LENA were produced containing BlaM enzyme molecules as many as Gag per capsid, which has been reported to be ∼5000 molecules, but lacking the viral genome. Infection of 293T and MT-4 cells by VSV-G-pseudotyped BlaM-containing LENA led to successful transduction of BlaM molecules into the cell cytoplasm, as detected by cleavage of the fluorescent BlaM substrate CCF2-AM. LENA-mediated transient protein transduction does not damage cellular DNA, and the preparation of highly purified protein is not necessary. This technology is potentially useful in various basic and clinical applications.
journal_name
Gene Therjournal_title
Gene therapyauthors
Aoki T,Miyauchi K,Urano E,Ichikawa R,Komano Jdoi
10.1038/gt.2011.38subject
Has Abstractpub_date
2011-09-01 00:00:00pages
936-41issue
9eissn
0969-7128issn
1476-5462pii
gt201138journal_volume
18pub_type
杂志文章相关文献
GENE THERAPY文献大全abstract：:First-generation adenoviral (Ad) vectors are frequently used vectors for experimental and clinical gene transfer. Earlier it has been shown that parallel overexpression of the cell cycle regulator p21(Waf1/Cip1) (p21) or antiapoptotic bcl-2 from a second vector reduces cytotoxicity and improves transgene expression. H...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.2
更新日期：2009-04-01 00:00:00
abstract：:Attempts have been made to use various forms of cellular vectors to deliver therapeutic genes to diseased tissues like malignant tumours. However, this approach has proved problematic due to the poor uptake of these vectors by the target tissue. We have devised a novel way of using magnetic nanoparticles (MNPs) to enh...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2008.57
更新日期：2008-06-01 00:00:00
abstract：:Several groups are assessing the use of cationic lipids for respiratory gene therapy. To date no human data are available regarding the safety of intra-pulmonary cationic lipid delivery. In preparation for a trial of pulmonary delivery of the CFTR gene, we have assessed the safety of nebulised lipid GL-67/DOPE/DMPE-PE...
journal_title：Gene therapy
pub_type： 临床试验,杂志文章
doi：10.1038/sj.gt.3300481
更新日期：1997-09-01 00:00:00
abstract：:Gyrate atrophy (GA) of the choroid and retina is an autosomal recessive chorioretinal degeneration, caused by deficiency of the mitochondrial matrix enzyme ornithine-delta-aminotransferase (OAT). This deficiency results in the accumulation of ornithine in the body fluids and leads to hyperornithinemia. Although the cl...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1995-01-01 00:00:00
abstract：:Somatic gene transfer to the pulmonary endothelium may be a useful strategy for modifying the phenotype of endothelium and/or vascular smooth muscle in disorders such as primary pulmonary hypertension, ARDS or pulmonary metastatic disease. Adenoviral (Ad) vectors, although highly efficient in liver gene transfer, have...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301636
更新日期：2002-02-01 00:00:00
abstract：:Efficient transduction of the peripheral nervous system (PNS) is required for gene therapy of acquired and inherited neuropathies, neuromuscular diseases and for pain treatment. We have characterized the tropism and transduction efficiency of different adeno-associated vectors (AAV) pseudotypes after sciatic nerve inj...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2011.7
更新日期：2011-06-01 00:00:00
abstract：:The structure of 'stabilized plasmid-lipid particles' (SPLP) and their properties as systemic gene therapy vectors has been investigated. We show that SPLP can be visualized employing cryo-electron microscopy to be homogeneous particles of diameter 72 +/- 5 nm consisting of a lipid bilayer surrounding a core of plasmi...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301308
更新日期：2000-11-01 00:00:00
abstract：:Pancreatic cancer and chronic pancreatitis are clinical syndromes associated with severe pain that is difficult to manage. Thus, seeking additional pain reduction therapies is warranted. Excessive alcohol consumption over an extended period of time is the primary causal agent in pancreatitis. The efficacy of a replica...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/gt.2009.27
更新日期：2009-04-01 00:00:00
abstract：:Overexpression of vascular endothelial growth factor (VEGF) and its cognate receptor KDR has been linked to a more aggressive phenotype of human prostate carcinomas. The importance of signal transduction through the VEGF receptor 2 is illustrated by use of soluble KDR, which binds to VEGF and sequesters this ligand be...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302432
更新日期：2005-03-01 00:00:00
abstract：:Intramuscular (i.m.) injection of plasmids followed by electropermeabilization is an efficient process to deliver genes into skeletal myofibers that permits proteins to be produced and secreted at therapeutically relevant levels. To further improve skeletal muscle as a bioreactor, we identified a formulation that elev...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301806
更新日期：2002-10-01 00:00:00
abstract：:RNA interference (RNAi) was reported to block hepatitis B virus (HBV) gene expression and replication in vitro and in vivo. However, it remains a technical challenge for RNAi-based therapy to achieve long-term and complete inhibition effects in chronic HBV infection, which presumably requires more extensive and unifor...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302846
更新日期：2007-01-01 00:00:00
abstract：:A stable single vial lipoplex formulation has been developed that can be stored frozen without losing either biological activity or physical stability. This formulation was identified by systematically controlling several formulation variables and without introducing either stabilizers or surfactants. Analytical assay...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300707
更新日期：1998-09-01 00:00:00
abstract：:The ability to restrict gene delivery and expression to particular cell types is of paramount importance for many types of gene therapy, especially in the lung. The alveolar epithelial type I (ATI) cell, in particular, is an attractive cell type to target, as it comprises 95% of the internal surface area of the lung. ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2016.52
更新日期：2016-10-01 00:00:00
abstract：:Despite significant advances in basic research, the treatment of degenerative diseases of the nervous system remains one of the greatest challenges for translational medicine. The childhood onset motor neuron disorder spinal muscular atrophy (SMA) has been viewed as one of the more tractable targets for molecular ther...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/gt.2017.52
更新日期：2017-09-01 00:00:00
abstract：:Alveolar bone loss associated with periodontal diseases is the result of osteoclastogenesis induced by bacterial pathogens. The mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a critical negative regulator of immune response as a key phosphatase capable of dephosphorylating activated MAPKs. In this st...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.139
更新日期：2011-04-01 00:00:00
abstract：:Therapeutic RNA interference (RNAi) has emerged as a promising approach for the treatment of many incurable diseases, including cancer, infectious disease or neurodegenerative disorders. Demonstration of efficacy and safety in animal models is necessary before planning human application. Our group and others have prev...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2011.10
更新日期：2011-07-01 00:00:00
abstract：:RNA interference (RNAi) is an evolutionarily conserved process by which plants and animals protect their genomes utilizing small, double-stranded RNAs to degrade target RNAs in a sequence-specific manner. Post-transcriptional gene silencing by these moieties can lead to degradation of both cellular and viral RNAs. It ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302339
更新日期：2004-12-01 00:00:00
abstract：:Production of retroviral vectors for clinical use requires removal of cells and cellular debris. We combined a series of filters of decreasing pore size using commercially available blood banking filters approved for clinical use. The collection bag and filters can be connected to create a sterile, closed system using...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301328
更新日期：2000-12-01 00:00:00
abstract：:A novel method of in vivo targeted gene transfer to intentionally selected areas of the corneal endothelium was developed. Plasmid DNA with the lacZ gene coding for beta-galactosidase was injected into the anterior chamber of adult Wistar rats, and eight pulses of electricity at intensities ranging from 5 to 40 V/cm w...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300725
更新日期：1998-10-01 00:00:00
abstract：:Radioiodide concentrating activity in the thyroid, mediated by human Na+/I- symporter (hNIS), provides a mechanism for effective radioiodide treatment for patients who have invasive, recurrent, and metastatic thyroid cancers after total thyroidectomy. In an attempt to develop hNIS gene transfer for radioiodide therapy...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301170
更新日期：2000-05-01 00:00:00
abstract：:The oncotropic phenotypes of several viruses correlate with tumor-associated deficiencies within interferon (IFN) signaling pathways. This observation formed the conceptual basis for developing oncolytic viruses deleted for viral proteins that inhibit the host IFN-dependent antiviral response, such as herpes simplex v...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.68
更新日期：2009-09-01 00:00:00
abstract：:Gene transfer vectors encoding two or more genes are potentially powerful research tools and are poised to play an increasingly important role in gene therapy applications. Common strategies employed to express more than one transgene per vector include the use of multiple promoters, internal ribosome entry site (IRES...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3303105
更新日期：2008-03-01 00:00:00
abstract：:Current generation adenovirus (Ad) vectors are deleted for the E1 region of genes and require propagation in E1 expressing 293 cells. Expression of genes delivered by Ad vectors into immunocompetent hosts is generally transient since the current vectors are not completely replication defective. Viral proteins expresse...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300378
更新日期：1997-03-01 00:00:00
abstract：:Studies reviewed show that lentiviral gene therapy directed either at inhibiting the synthesis of brain acetaldehyde generated from ethanol or at degrading brain acetaldehyde fully prevent ethanol intake by rats bred for their high alcohol preference. However, after animals have chronically consumed alcohol, the above...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/s41434-019-0064-9
更新日期：2019-11-01 00:00:00
abstract：:The CMV promoter drives high transgene expression and is one of the most commonly used promoters for gene transfer. Tissue-specific mammalian promoters provide an alternative, and it would be useful to have a system to directly compare them to viral promoters free from potential confounding vector-related effects. In ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302700
更新日期：2006-05-01 00:00:00
abstract：:Cytomegalovirus (CMV) promoter is often present in recombinant adenovirus vectors (AdVs) suitable for gene therapy, ensuring high levels of transgene production in a wide range of hosts. Despite this characteristic, the presence of the AdV genome in target cells and tissues typically lasts longer than transgene produc...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301296
更新日期：2000-10-01 00:00:00
abstract：:Chimeric antigen receptor (CAR) T-cell therapies have demonstrated durable and potentially curative therapeutic efficacy against B-cell leukemia in clinical trials. A CAR strategy can target any tumor surface antigens as long as an antigen-binding receptor can be generated. New CARs that target solid tumors and have t...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.29
更新日期：2015-08-01 00:00:00
abstract：:Parkinson's disease is a prevalent progressive degenerative disorder of the elderly. There is a current need for novel therapeutic strategies because the standard levodopa pharmacotherapy is only temporarily efficacious. Recently, there have been some high-profile successful preclinical results obtained in animal mode...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3302669
更新日期：2006-03-01 00:00:00
abstract：:Foamy virus (FV) vectors are promising for hematopoietic stem cell (HSC) gene therapy but preclinical data on the clonal composition of FV vector-transduced human repopulating cells is needed. Human CD34(+) human cord blood cells were transduced with an FV vector encoding a methylguanine methyltransferase (MGMT)P140K ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.20
更新日期：2015-07-01 00:00:00
abstract：:The development of efficient systems for in vivo gene transfer to the central nervous system (CNS) may provide a useful therapeutic strategy for the alleviation of several neurological disorders. In this study, we evaluated the feasibility of nonviral gene therapy to the CNS mediated by cationic liposomes. We present ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302516
更新日期：2005-08-01 00:00:00
